Renal Biomarkers Industry Overview 2025: Growth Projections and Market Trends

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Renal Biomarkers Market?

The renal biomarkers market size has experienced significant expansion in recent years. It is anticipated to increase from $1.28 billion in 2024 to $1.37 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.4%. This past growth can be attributed to the rising occurrence of kidney diseases, developments in medical diagnostics, an aging population, increasing recognition of early disease detection, the implementation of point-of-care testing, and a surge in chronic diseases.

The renal biomarkers market is projected to undergo significant expansion in the upcoming years, with an anticipated valuation of $1.9 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.4%. This projected growth throughout the forecast period stems from factors such as the increasing focus on personalized medicine and targeted therapies, the broader integration of biomarker testing into routine clinical practice, the opportunities presented by emerging markets in Asia and Latin America, advancements in non-invasive biomarker testing methods, and the rise of continuous monitoring via wearable devices. Furthermore, major trends anticipated during this period encompass the utilization of multiplex biomarker panels for comprehensive disease profiling, the application of AI and machine learning in biomarker discovery, the development of biomarker-based companion diagnostics, the availability of point-of-care (POC) biomarker testing in home healthcare settings, and the ongoing search for biomarkers crucial for early detection and prevention.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7711&type=smp

Which Major Market Drivers Are Shaping The Future Of The Renal Biomarkers Market?

The increasing number of geriatric and pediatric renal patients is anticipated to propel the growth of the renal biomarkers market going forward. Geriatric renal patients are categorized as elderly individuals aged above 70 years who have advanced chronic kidney disease (CKD). Conversely, pediatric renal patients are those who are typically diagnosed with a renal disorder during their childhood and young adulthood. Renal biomarkers are instrumental in assessing the severity of renal injury in both geriatric and pediatric renal patients. For instance, in June 2024, data from the Australian Institute of Health and Welfare, an Australia-based government agency, revealed that chronic kidney disease (CKD) mortality rates climbed by 4.2% in 2021 and 6.2% in 2022. Therefore, the rising prevalence of geriatric and pediatric renal patients is a key driver for the expansion of the renal biomarkers market.

What Are The Different Segment Classifications Within The Renal Biomarkers Market?

The renal biomarkersmarket covered in this report is segmented –

1) By Biomarker Type: Functional Biomarker; Up Regulated Protein; Other Biomarker Types

2) By Diagnostic Technique: Enzyme-Linked Immunosorbent Assay; Particle-Enhanced Turbidimetric Immunoassay (PETIA); Colorimetric Assay; Chemiluminescent Enzyme Immunoassay (CLIA); Liquid Chromatography Mass Spectrometry (LS-MS)

3) By Application: Diagnosis And Disease Progression Monitoring; Research Homecare

4) By End User: Hospitals; Diagnostic Laboratories; Other End Users

Subsegments:

1) By Functional Biomarker: Creatinine; Urea; Cystatin C; Bicarbonate

2) By Up Regulated Protein: Neutrophil Gelatinase-Associated Lipocalin (NGAL); Kidney Injury Molecule-1 (KIM-1); Interleukin-18 (IL-18)

3) By Other Biomarker Types: Proximal Tubule Injury Biomarkers; Acute Kidney Injury Biomarkers; Chronic Kidney Disease Biomarkers

What Are The Latest Industry Trends Transforming The Renal Biomarkers Market?

Technological breakthroughs have emerged as a primary trend gaining momentum within the renal biomarkers market. Key companies operating in the renal biomarkers sector are concentrating on developing novel technologies to maintain their market position. For instance, in March 2022, Nipro Medical Corporation, a US-based medical equipment manufacturing company, introduced SURDIAL DX. The SURDIAL DX hemodialysis system is a sophisticated device, incorporating advanced technology for superior patient safety, comfort, and efficiency. It boasts modern design features such as optimized automated processes, an ergonomic layout, and a commitment to elevating the overall dialysis treatment experience.

Which Global Market Leaders Are Shaping The Future Of The Renal Biomarkers Sector?

Major companies operating in the renal biomarkers market include Abbott Laboratories, BioPorto Diagnostics A/S, Roche Holding AG, Thermo Fisher Scientific, bioMérieux SA, Randox Laboratories, Siemens Healthineers, Beckman Coulter Inc., Astute Medical Inc., Nexelis Company, Sphingotec GmbH, Bio-Rad Laboratories India Pvt. Ltd., Enzo Biochem Inc., PerkinElmer Inc., Novartis AG, Alere Inc., AstraZeneca plc, Bio-Techne Corp., DiaSorin S.p.A., EKF Diagnostics Holdings plc, Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Merck KGaA, Myriad RBM Inc., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, R&D Systems Inc., Roche Diagnostics International Ltd ., Sekisui Chemical Co. Ltd., Sysmex Corporation, Tosoh Bioscience Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report

Which Region Currently Holds The Largest Share Of The Renal Biomarkers Market?

North America was the largest region in the renal biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region during the forecast period. The regions covered in the renal biomarkers market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Renal Biomarkers Market Report:

https://www.thebusinessresearchcompany.com/customise?id=7711&type=smp

Browse Through More Reports Similar to the Global Renal Biomarkers Market 2025, By The Business Research Company

Site Remediation Consulting Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/site-remediation-consulting-services-global-market-report

Psoriasis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report

Scientific Research And Development Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/scientific-research-and-development-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795